• The global Gene Synthesis market was valued at US$ 576 million in 2023 and is anticipated to reach US$ 1661 million by 2030, witnessing a CAGR of 16.35% during the forecast period 2024-2030.
• North American market for Gene Synthesis is estimated to increase from $ 198.42 million in 2023 to reach $ 477 million by 2030, at a CAGR of 13.48% during the forecast period of 2024 through 2030.
Email:
• The major global companies of Gene Synthesis include GenScript, Thermo Scientific, IDT, DNA 2.0 (ATUM), Twist Bioscience, BBI, Azenta Life Sciences, Eurofins Genomics, Gene Oracle, SBS Genetech, etc. In 2023, the world's top five vendors accounted for approximately 72.41% of the revenue.
• This report aims to provide a comprehensive presentation of the global market for Gene Synthesis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Gene Synthesis.
• The Gene Synthesis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Synthesis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
Email: help@intelmarketresearch.com +91 9169164321
• Below 1000 bp
• 1001-3000 bp
• 3001-5000 bp
• Above 5000 bp
Genescript
Thermo Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
